Tumor-necrosis factor impairs CD4+ T cell–mediated immunological control in chronic viral infection

[1]  Paul A. Lyons,et al.  T cell exhaustion, costimulation and clinical outcome in autoimmunity and infection , 2015, Nature.

[2]  C. Hunter,et al.  IL-6 as a keystone cytokine in health and disease , 2015, Nature Immunology.

[3]  A. Oxenius,et al.  Regulation of antiviral T cell responses by type I interferons , 2015, Nature Reviews Immunology.

[4]  A. Sher,et al.  Type I interferons in infectious disease , 2015, Nature Reviews Immunology.

[5]  A. Carrillo-Vico,et al.  TNF-α levels in HIV-infected patients after long-term suppressive cART persist as high as in elderly, HIV-uninfected subjects. , 2014, The Journal of antimicrobial chemotherapy.

[6]  D. Speiser,et al.  T cell differentiation in chronic infection and cancer: functional adaptation or exhaustion? , 2014, Nature Reviews Immunology.

[7]  L. BenMohamed,et al.  HIV-1 Tat Protein Induces PD-L1 (B7-H1) Expression on Dendritic Cells through Tumor Necrosis Factor Alpha- and Toll-Like Receptor 4-Mediated Mechanisms , 2014, Journal of Virology.

[8]  Burton E. Barnett,et al.  Molecular and transcriptional basis of CD4⁺ T cell dysfunction during chronic infection. , 2014, Immunity.

[9]  D. Douek,et al.  Systemic effects of inflammation on health during chronic HIV infection. , 2013, Immunity.

[10]  B. Becher,et al.  TGF-β Signalling Is Required for CD4+ T Cell Homeostasis But Dispensable for Regulatory T Cell Function , 2013, PLoS biology.

[11]  R. Schreiber,et al.  Persistent LCMV Infection Is Controlled by Blockade of Type I Interferon Signaling , 2013, Science.

[12]  B. Aronow,et al.  Blockade of Chronic Type I Interferon Signaling to Control Persistent LCMV Infection , 2013, Science.

[13]  M. Sade-Feldman,et al.  Tumor necrosis factor-α blocks differentiation and enhances suppressive activity of immature myeloid cells during chronic inflammation. , 2013, Immunity.

[14]  T. Mak,et al.  Reactive oxygen species delay control of lymphocytic choriomeningitis virus , 2013, Cell Death and Differentiation.

[15]  E John Wherry,et al.  Network analysis reveals centrally connected genes and pathways involved in CD8+ T cell exhaustion versus memory. , 2012, Immunity.

[16]  C. Massone,et al.  Safety of anti-tumour necrosis factor agents in patients with chronic hepatitis C infection: a systematic review. , 2011, Rheumatology.

[17]  R. Balderas,et al.  Repression of the genome organizer SATB1 in regulatory T cells is required for suppressive function and inhibition of effector differentiation , 2011, Nature Immunology.

[18]  S. Ghosh,et al.  Crosstalk in NF-κB signaling pathways , 2011, Nature Immunology.

[19]  E. Wherry.  T cell exhaustion , 2011, Nature Immunology.

[20]  D. Kaufmann,et al.  HIV-specific CD4 T cells and immune control of viral replication , 2011, Current opinion in HIV and AIDS.

[21]  E. Rosenberg,et al.  Transcriptional Profiling of CD4 T Cells Identifies Distinct Subgroups of HIV-1 Elite Controllers , 2010, Journal of Virology.

[22]  R. Obst,et al.  Role of antigen persistence and dose for CD4+ T-cell exhaustion and recovery , 2010, Proceedings of the National Academy of Sciences.

[23]  S. Sehrawat,et al.  Immunity and immunopathology to viruses: what decides the outcome? , 2010, Nature Reviews Immunology.

[24]  R. Ahmed,et al.  Features of responding T cells in cancer and chronic infection. , 2010, Current opinion in immunology.

[25]  D. Solomon,et al.  Tumor necrosis factor blockade and the risk of viral infection , 2010, Nature Reviews Rheumatology.

[26]  Kristen K. Dang,et al.  Genome-Wide mRNA Expression Correlates of Viral Control in CD4+ T-Cells from HIV-1-Infected Individuals , 2010, PLoS pathogens.

[27]  S. Habib,et al.  Infliximab therapy for HIV positive Crohn's disease: A case report. , 2009, Journal of Crohn's & colitis.

[28]  G. McFadden,et al.  Cytokine determinants of viral tropism , 2009, Nature Reviews Immunology.

[29]  A. Zajac,et al.  A Vital Role for Interleukin-21 in the Control of a Chronic Viral Infection , 2009, Science.

[30]  K. Sauer,et al.  IL-21 Is Required to Control Chronic Viral Infection , 2009, Science.

[31]  J. Weber,et al.  IL-21R on T Cells Is Critical for Sustained Functionality and Control of Chronic Viral Infection , 2009, Science.

[32]  G. Freeman,et al.  PD-1 and its ligands in tolerance and immunity. , 2008, Annual review of immunology.

[33]  J. Reveille,et al.  The use of anti-tumour necrosis factor therapy in HIV-positive individuals with rheumatic disease , 2007, Annals of the rheumatic diseases.

[34]  Tanya M. Teslovich,et al.  Chronic CD4+ T-Cell Activation and Depletion in Human Immunodeficiency Virus Type 1 Infection: Type I Interferon-Mediated Disruption of T-Cell Dynamics , 2007, Journal of Virology.

[35]  T. Zander,et al.  RNA fingerprints provide direct evidence for the inhibitory role of TGFbeta and PD-1 on CD4+ T cells in Hodgkin lymphoma. , 2007, Blood.

[36]  E. Wherry,et al.  Molecular signature of CD8+ T cell exhaustion during chronic viral infection. , 2007, Immunity.

[37]  J. Christensen,et al.  Differential induction of CD94 and NKG2 in CD4 helper T cells. A consequence of influenza virus infection and interferon‐γ? , 2007, Immunology.

[38]  P. Lambert,et al.  Protracted Course of Lymphocytic Choriomeningitis Virus WE Infection in Early Life: Induction but Limited Expansion of CD8+ Effector T Cells and Absence of Memory CD8+ T Cells , 2007, Journal of Virology.

[39]  K. Rajewsky,et al.  Canonical NF-kappaB activity, dispensable for B cell development, replaces BAFF-receptor signals and promotes B cell proliferation upon activation. , 2006, Immunity.

[40]  J. Mesirov,et al.  From the Cover: Gene set enrichment analysis: A knowledge-based approach for interpreting genome-wide expression profiles , 2005 .

[41]  R. Jonsson,et al.  A regulatory polymorphism in PDCD1 is associated with susceptibility to systemic lupus erythematosus in humans , 2002, Nature Genetics.

[42]  R. Pollard,et al.  Kinetics of tumor necrosis factor alpha and soluble TNFRII in HIV-infected patients treated with a triple combination of stavudine, didanosine, and hydroxyurea. , 1997, AIDS research and human retroviruses.

[43]  S. Frøland,et al.  Effects of intravenous immunoglobulin in vivo on abnormally increased tumor necrosis factor-alpha activity in human immunodeficiency virus type 1 infection. , 1997, The Journal of infectious diseases.

[44]  N. Liabakk,et al.  Serum Levels of Tumor Necrosis Factor-α (TNFα) and Soluble TNF Receptors in Human Immunodeficiency Virus Type 1 Infection-Correlations to Clinical, Immunologic, and Virologic Parameters , 1994 .

[45]  P. Borrow,et al.  Molecular basis of viral persistence: a single amino acid change in the glycoprotein of lymphocytic choriomeningitis virus is associated with suppression of the antiviral cytotoxic T-lymphocyte response and establishment of persistence , 1991, Journal of virology.

[46]  R. Ahmed,et al.  Selection of genetic variants of lymphocytic choriomeningitis virus in spleens of persistently infected mice. Role in suppression of cytotoxic T lymphocyte response and viral persistence , 1984, The Journal of experimental medicine.

[47]  M. V. Doyle,et al.  Susceptibility of newborn mice with H-2k backgrounds to lymphocytic choriomeningitis virus infection. , 1980, Immunology.

[48]  E. Wherry,et al.  Acquired transcriptional programming in functional and exhausted virus-specific CD8 T cells. , 2012, Current opinion in HIV and AIDS.

[49]  H. Lodish,et al.  Troglitazone antagonizes tumor necrosis factor-alpha-induced reprogramming of adipocyte gene expression by inhibiting the transcriptional regulatory functions of NF-kappaB. , 2003, The Journal of biological chemistry.

[50]  N. Liabakk,et al.  Tumor necrosis factor (TNF) system levels in human immunodeficiency virus-infected patients during highly active antiretroviral therapy: persistent TNF activation is associated with virologic and immunologic treatment failure. , 1999, The Journal of infectious diseases.